Education
About Us
Working with TipRanks
Follow Us
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
KIDS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$21.02 - $35.99
Previous CloseN/A
Volume20.12K
Average Volume (3M)225.43K
Market Cap
$598.18M
Enterprise Value$626.52M
Total Cash (Recent Filing)-$6.58M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.14
Next Earnings
Apr 30, 2025EPS Estimate
-0.43Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.64
Shares Outstanding24,286,590
10 Day Avg. Volume135,817
30 Day Avg. Volume225,428
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.96
Price to Cash Flow (P/CF)-38.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.05
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.22
Enterprise Value/Ebitda-59.87
Forecast
1Y Price Target
$39.00Price Target Upside55.69% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
---
OrthoPediatrics News
PremiumCompany Announcements
OrthoPediatrics Corp’s Earnings Call Highlights Growth and Record Impact
PremiumCompany Announcements
OrthoPediatrics Corp. Reports Strong 2024 Financial Growth---
Bulls Say, Bears Say
Bulls Say
Growth PotentialKIDS continues to be a differentiated participant in the largely underserved pediatric-orthopedic industry, with potential to achieve further penetration in its base markets and enter complementary, attractive orthopedic arenas.
Market ShareKIDS posted revenues in line with its preannounced figures as the company continues to take share across segments in its pediatric-orthopedic niche.
Revenue GrowthStrong revenue growth is expected to sustain driven by factors such as improving US procedure volumes, new product launches, clinic expansion, new account openings, and international expansion.
Bears Say
Cost ManagementGross margin was down 350 bps Y/Y driven by a full-year adjustment of certain G&A expenses into COGS.
Financial GuidanceThe initial 2025 sales guidance and adjusted EBITDA target are both below Street numbers.
Segment PerformanceSports Medicine/Other showed a decline of 29.2% year over year, reflecting a negative trend in this segment.
---
Ownership Overview
32.36% Insiders
16.77% Mutual Funds
25.60% Other Institutional Investors
16.73% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KIDS FAQ
What was OrthoPediatrics Corp’s price range in the past 12 months?
OrthoPediatrics Corp lowest stock price was $21.02 and its highest was $35.99 in the past 12 months.
What is OrthoPediatrics Corp’s market cap?
OrthoPediatrics Corp’s market cap is $598.18M.
When is OrthoPediatrics Corp’s upcoming earnings report date?
OrthoPediatrics Corp’s upcoming earnings report date is Apr 30, 2025 which is in 27 days.
How were OrthoPediatrics Corp’s earnings last quarter?
OrthoPediatrics Corp released its earnings results on Mar 04, 2025. The company reported -$0.29 earnings per share for the quarter, beating the consensus estimate of -$0.301 by $0.011.
Is OrthoPediatrics Corp overvalued?
According to Wall Street analysts OrthoPediatrics Corp’s price is currently Undervalued.
Does OrthoPediatrics Corp pay dividends?
OrthoPediatrics Corp does not currently pay dividends.
What is OrthoPediatrics Corp’s EPS estimate?
OrthoPediatrics Corp’s EPS estimate is -0.43.
How many shares outstanding does OrthoPediatrics Corp have?
OrthoPediatrics Corp has 24,286,590 shares outstanding.
What happened to OrthoPediatrics Corp’s price movement after its last earnings report?
OrthoPediatrics Corp reported an EPS of -$0.29 in its last earnings report, beating expectations of -$0.301. Following the earnings report the stock price went up 11.883%.
Which hedge fund is a major shareholder of OrthoPediatrics Corp?
Currently, no hedge funds are holding shares in KIDS
---
OrthoPediatrics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$39.00 (55.69% Upside)
$39.00 (55.69% Upside)
Hedge Fund Trend
Decreased
By 8.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $721.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.13%
12-Months-Change
Fundamentals
Return on Equity
-10.34%
Trailing 12-Months
Asset Growth
7.59%
Trailing 12-Months
Company Description
OrthoPediatrics Corp
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
---
KIDS Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
OrthoPediatrics reported strong growth and record patient impact for 2024, with significant revenue and adjusted EBITDA improvements. Despite challenges with international sales and gross margin declines due to expense reclassifications, the company remains on track with positive growth projections, successful integration efforts, and new product launches. The restructuring efforts and strategic decisions are aimed at driving long-term profitability.Read More>---
KIDS Stock 12 Month Forecast
Average Price Target
$39.00
▲(55.69% Upside)
Technical Analysis
Best Analysts Covering KIDS
1 Year
1 Year Success Rate
6/28 ratings generated profit
1 Year Average Return
-17.52%
reiterated a buy rating last month
Copying Ryan Zimmerman's trades and holding each position for 1 Year would result in 21.43% of your transactions generating a profit, with an average return of -17.52% per trade.
---